Suppr超能文献

[从麻醉学角度看目前常规采用血液保护措施的可能性——理论基础与临床实践。IV:促红细胞生成素与铁剂的支持性给药]

[The present possibilities for routine use of blood-saving measures from the anesthesiologic point of view--theoretical bases and clinical practice. IV: Supportive administration of erythropoietin and iron].

作者信息

Singbartl G

机构信息

Abteilung Anästhesiologie, Intensiv- und Transfusionsmedizin, ENDO-KLINIK Hamburg.

出版信息

Anaesthesiol Reanim. 1994;19 Suppl:25-31.

PMID:8148015
Abstract

In clinical studies erythropoietin has been shown to effectively increase the autologous predeposit in patients undergoing elective surgery; however, the results demonstrating a reduction of homologous transfusion are not equally convincing. Besides the administration of erythropoietin in preoperative blood donation the necessity of which is to be questioned as a routine measure due to the efficacy of apparative-technical methods, more distinct and more specific indications probably emerge for this pharmacological support: preoperative administration of erythropoietin in anemic patients incapable of donating an autologous predeposit, anemic patients unable to undergo an elective surgical intervention due to the severity of the pre-existing anemia, patients who refuse autologous predeposit as well as homologous blood transfusions for religious reasons, and finally short term perioperative (pre- and/or postoperative) administration for reducing the period and the extent of postoperative anemia.

摘要

在临床研究中,促红细胞生成素已被证明能有效增加择期手术患者的自体预存血量;然而,关于其能减少异体输血的结果并不同样令人信服。除了在术前自体献血时使用促红细胞生成素外,由于仪器技术方法的有效性,其作为常规措施的必要性值得质疑,对于这种药物支持可能会出现更明确、更具体的适应证:对无法进行自体预存献血的贫血患者、因原有贫血严重程度而无法进行择期手术干预的贫血患者、因宗教原因拒绝自体预存献血以及异体输血的患者,最后是短期围手术期(术前和/或术后)使用以缩短术后贫血时间和减轻贫血程度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验